Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 101

Azuga acquires Mobikit

Ohio State University’s insurtech developer Mobikit has been bought by Azuga for an undisclosed amount.

Mar 11, 2021

Northvolt cuts acquisition deal with Cuberg

Boeing HorizonX has exited Cuberg three years after investing in the battery cell technology developer.

Mar 11, 2021

Paypal picks Curv for acquisition

CommerzBank, Monex Group, Coinbase and Digital Garage are set to exit the digital wallet provider in a Paypal acquisition reportedly sized below $200m.

Mar 10, 2021

Grifols grabs GigaGen in $80m acquisition

Grifols has agreed to buy the remaining 56% of antibody drug developer GigaGen having invested $35m four years ago.

Mar 10, 2021

Evolv graduates to $1.25bn reverse merger

Duke University's contactless security system developer agrees to list through a reverse takeover, providing an exit to OUP.

Mar 10, 2021

Design Therapeutics drafts IPO filing

UW Madison’s small-molecule therapy spinout has raised $170m in venture funding since emerging from stealth less than a year ago.

Mar 10, 2021

Roblox locks up direct listing

The Tencent and Warner Music-backed game development platform looks set to maintain its $29.5bn valuation in its direct listing today.

Mar 10, 2021

Evolv graduates to $1.25bn reverse merger

Motorola Solutions is among the participants supplying $300m in PIPE financing as the contactless security system developer agrees to list through a reverse takeover.

Mar 10, 2021

DTCP accepts Axonius stake in $270m deal

Deutsche Telekom-backed DTCP was among a group of investors that acquired a $270m stake in the cybersecurity management platform developer in a secondary transaction.

Mar 10, 2021

Edgewise nears $100m IPO

Novo will exit the musculoskeletal disease drug developer, should the latter complete an initial public offering on the Nasdaq Global Market.

Mar 10, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here